{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:04:54Z","timestamp":1785819894525,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,15]]},"DOI":"10.7759\/cureus.19615","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T07:32:53Z","timestamp":1637047973000},"source":"Crossref","is-referenced-by-count":11,"title":["The Burden of Undiagnosed Adults With Attention-Deficit\/Hyperactivity Disorder Symptoms in Japan: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Noriyuki","family":"Naya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinaga","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungeun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. American Psychiatric Association, Washington, DC; 2013. 10.1176\/appi.books.9780890425596"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.10.005","article-title":"Childhood predictors of adult attention-deficit\/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative","volume":"65","author":"Lara C","year":"2009","unstructured":"Lara C, Fayyad J, de Graaf R, et al.. Childhood predictors of adult attention-deficit\/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry. 2009, 65:46-54. 10.1016\/j.biopsych.2008.10.005","journal-title":"Biol Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ambp.2006.07.006","article-title":"Attention-deficit\/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology","volume":"7","author":"Spencer TJ","year":"2007","unstructured":"Spencer TJ, Biederman J, Mick E. Attention-deficit\/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. Ambul Pediatr. 2007, 7:73-81. 10.1016\/j.ambp.2006.07.006","journal-title":"Ambul Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1471","article-title":"Twenty-year trends in diagnosed attention-deficit\/hyperactivity disorder among US children and adolescents, 1997-2016","volume":"1","author":"Xu G","year":"2018","unstructured":"Xu G, Strathearn L, Liu B, Yang B, Bao W. Twenty-year trends in diagnosed attention-deficit\/hyperactivity disorder among US children and adolescents, 1997-2016. JAMA Netw Open. 2018, 1:e181471. 10.1001\/jamanetworkopen.2018.1471","journal-title":"JAMA Netw Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.11.04009","article-title":"The prevalence of adult attention-deficit hyperactivity disorder: a global systematic review and meta-analysis","volume":"11","author":"Song P","year":"2021","unstructured":"Song P, Zha M, Yang Q, Zhang Y, Li X, Rudan I. The prevalence of adult attention-deficit hyperactivity disorder: a global systematic review and meta-analysis. J Glob Health. 2021, 11:04009. 10.7189\/jogh.11.04009","journal-title":"J Glob Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.034389","article-title":"Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder","volume":"190","author":"Fayyad J","year":"2007","unstructured":"Fayyad J, De Graaf R, Kessler R, et al.. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007, 190:402-9. 10.1192\/bjp.bp.106.034389","journal-title":"Br J Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1087054707299597","article-title":"Trends in medication treatment for ADHD","volume":"10","author":"Castle L","year":"2007","unstructured":"Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS. Trends in medication treatment for ADHD. J Atten Disord. 2007, 10:335-42. 10.1177\/1087054707299597","journal-title":"J Atten Disord"},{"key":"ref8","article-title":"Epidemiological survey of adult attention deficit hyperactivity disorder (ADHD) in Japan [In Japanese]","volume":"155","author":"Nakamura S","year":"2013","unstructured":"Nakamura S, Ohnishi M, Uchiyama S. Epidemiological survey of adult attention deficit hyperactivity disorder (ADHD) in Japan [In Japanese]. Jpn J Psychiatr Treat. 2013, 155:62.","journal-title":"Jpn J Psychiatr Treat"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.048827","article-title":"Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis","volume":"194","author":"Simon V","year":"2009","unstructured":"Simon V, Czobor P, B\u00e1lint S, M\u00e9sz\u00e1ros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009, 194:204-11. 10.1192\/bjp.bp.107.048827","journal-title":"Br J Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1087054716669589","article-title":"Adult ADHD and comorbid somatic disease: a systematic literature review","volume":"22","author":"Instanes JT","year":"2018","unstructured":"Instanes JT, Klungs\u00f8yr K, Halm\u00f8y A, Fasmer OB, Haavik J. Adult ADHD and comorbid somatic disease: a systematic literature review. J Atten Disord. 2018, 22:203-28. 10.1177\/1087054716669589","journal-title":"J Atten Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1087054718799367","article-title":"Health-related quality of life and work productivity of adults with ADHD: a U.K. web-based cross-sectional survey","volume":"23","author":"Joseph A","year":"2019","unstructured":"Joseph A, Kosmas CE, Patel C, Doll H, Asherson P. Health-related quality of life and work productivity of adults with ADHD: a U.K. web-based cross-sectional survey. J Atten Disord. 2019, 23:1610-23. 10.1177\/1087054718799367","journal-title":"J Atten Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132233","article-title":"Sociodemographics, comorbidities, healthcare utilization and work productivity in Japanese patients with adult ADHD","volume":"10","author":"Kirino E","year":"2015","unstructured":"Kirino E, Imagawa H, Goto T, Montgomery W. Sociodemographics, comorbidities, healthcare utilization and work productivity in Japanese patients with adult ADHD. PLoS One. 2015, 10:e0132233. 10.1371\/journal.pone.0132233","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2020.10.005","article-title":"Proinflammatory mediators and their associations with medication and comorbid traits in children and adults with ADHD","volume":"41","author":"Yang LL","year":"2020","unstructured":"Yang LL, Stiernborg M, Skott E, S\u00f6derstr\u00f6m \u00c5, Giacobini M, Lavebratt C. Proinflammatory mediators and their associations with medication and comorbid traits in children and adults with ADHD. Eur Neuropsychopharmacol. 2020, 41:118-31. 10.1016\/j.euroneuro.2020.10.005","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-020-01194-9","article-title":"Screening for adult ADHD","volume":"22","author":"Anbarasan D","year":"2020","unstructured":"Anbarasan D, Kitchin M, Adler LA. Screening for adult ADHD. Curr Psychiatry Rep. 2020, 22:72. 10.1007\/s11920-020-01194-9","journal-title":"Curr Psychiatry Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291704002892","article-title":"The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population","volume":"35","author":"Kessler RC","year":"2005","unstructured":"Kessler RC, Adler L, Ames M, et al.. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005, 35:245-56. 10.1017\/s0033291704002892","journal-title":"Psychol Med"},{"key":"ref16","unstructured":"World Health Organization. Adult ADHD Self-Report Scale-V1.1 (ASRS-V1.1) Symptoms Checklist from WHO Composite International Diagnostic Interview. (2003). Accessed: September 28, 2020: https:\/\/www.hcp.med.harvard.edu\/ncs\/ftpdir\/adhd\/18Q_ASRS_English.pdf."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2217\/npy.13.59","article-title":"Changes in the definition of ADHD in DSM-5: subtle but important","volume":"3","author":"Epstein JN","year":"2013","unstructured":"Epstein JN, Loren RE. Changes in the definition of ADHD in DSM-5: subtle but important. Neuropsychiatry (London). 2013, 3:455-8. 10.2217\/npy.13.59","journal-title":"Neuropsychiatry (London)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson ME","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40:373-83. 10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.01.006","article-title":"The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients","volume":"61","author":"Charlson ME","year":"2008","unstructured":"Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008, 61:1234-40. 10.1016\/j.jclinepi.2008.01.006","journal-title":"J Clin Epidemiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan H","year":"2011","unstructured":"Quan H, Li B, Couris CM, et al.. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011, 173:676-82. 10.1093\/aje\/kwq433","journal-title":"Am J Epidemiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2017.02.011","article-title":"Psychometric properties of the Japanese version of the Adult Attention-deficit hyperactivity disorder (ADHD) Self-Report Scale (ASRS-J) and its short scale in accordance with DSM-5 diagnostic criteria","volume":"63","author":"Takeda T","year":"2017","unstructured":"Takeda T, Tsuji Y, Kurita H. Psychometric properties of the Japanese version of the Adult Attention-deficit hyperactivity disorder (ADHD) Self-Report Scale (ASRS-J) and its short scale in accordance with DSM-5 diagnostic criteria. Res Dev Disabil. 2017, 63:59-66. 10.1016\/j.ridd.2017.02.011","journal-title":"Res Dev Disabil"},{"key":"ref22","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware JE Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30:473-83.","journal-title":"Med Care"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(98)00095-x","article-title":"Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan","volume":"51","author":"Fukuhara S","year":"1998","unstructured":"Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol. 1998, 51:1037-44. 10.1016\/s0895-4356(98)00095-x","journal-title":"J Clin Epidemiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol--a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990, 16:199-208. 10.1016\/0168-8510(90)90421-9","journal-title":"Health Policy"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-015-1108-2","article-title":"Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D","volume":"25","author":"Shiroiwa T","year":"2016","unstructured":"Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, Shimozuma K. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016, 25:707-19. 10.1007\/s11136-015-1108-2","journal-title":"Qual Life Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly MC","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993, 4:353-65. 10.2165\/00019053-199304050-00006","journal-title":"Pharmacoeconomics"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186503","article-title":"The influence of alcohol consumption on sickness presenteeism and impaired daily activities. the WIRUS screening study","volume":"12","author":"Aas RW","year":"2017","unstructured":"Aas RW, Haveraaen L, Sagvaag H, Th\u00f8rrisen MM. The influence of alcohol consumption on sickness presenteeism and impaired daily activities. the WIRUS screening study. PLoS One. 2017, 12:e0186503. 10.1371\/journal.pone.0186503","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S245486","article-title":"Adult obesity and health-related quality of life, patient activation, work productivity, and weight loss behaviors in the United States","volume":"13","author":"Rozjabek H","year":"2020","unstructured":"Rozjabek H, Fastenau J, LaPrade A, Sternbach N. Adult obesity and health-related quality of life, patient activation, work productivity, and weight loss behaviors in the United States. Diabetes Metab Syndr Obes. 2020, 13:2049-55. 10.2147\/DMSO.S245486","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2017.1352507","article-title":"Examining the association of smoking with work productivity and associated costs in Japan","volume":"20","author":"Suwa K","year":"2017","unstructured":"Suwa K, Flores NM, Yoshikawa R, Goto R, Vietri J, Igarashi A. Examining the association of smoking with work productivity and associated costs in Japan. J Med Econ. 2017, 20:938-44. 10.1080\/13696998.2017.1352507","journal-title":"J Med Econ"},{"key":"ref30","unstructured":"IBM Corp. IBM SPSS Statistics for Windows. (2017). Accessed: September 28, 2020: https:\/\/www.ibm.com\/products\/spss-statistics."},{"key":"ref31","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria. (2018). Accessed: September 28, 2020: https:\/\/www.r-project.org\/."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1159\/000508304","article-title":"Screened attention deficit\/hyperactivity disorder as a predictor of substance use initiation and escalation in early adulthood and the role of self-reported conduct disorder and sensation seeking: a 5-year longitudinal study with young adult Swiss men","volume":"26","author":"Moggi F","year":"2020","unstructured":"Moggi F, Schorno D, Soravia LM, Mohler-Kuo M, Est\u00e9vez-Lamorte N, Studer J, Gmel G. Screened attention deficit\/hyperactivity disorder as a predictor of substance use initiation and escalation in early adulthood and the role of self-reported conduct disorder and sensation seeking: a 5-year longitudinal study with young adult Swiss men. Eur Addict Res. 2020, 26:233-44. 10.1159\/000508304","journal-title":"Eur Addict Res"},{"key":"ref33","article-title":"The nature of the relationship between attention-deficit\/hyperactivity disorder and substance use","volume":"68 Suppl 11","author":"Wilens TE","year":"2007","unstructured":"Wilens TE. The nature of the relationship between attention-deficit\/hyperactivity disorder and substance use. J Clin Psychiatry. 2007, 68 Suppl 11:4-8.","journal-title":"J Clin Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.32827","article-title":"Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder","volume":"186","author":"Vilar-Rib\u00f3 L","year":"2021","unstructured":"Vilar-Rib\u00f3 L, S\u00e1nchez-Mora C, Rovira P, et al.. Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2021, 186:140-50. 10.1002\/ajmg.b.32827","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/1087054711435361","article-title":"Distinguishing comorbidity and successful management of adult ADHD","volume":"16","author":"Kooij JJ","year":"2012","unstructured":"Kooij JJ, Huss M, Asherson P, et al.. Distinguishing comorbidity and successful management of adult ADHD. J Atten Disord. 2012, 16:3S-19S. 10.1177\/1087054711435361","journal-title":"J Atten Disord"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28702-5","article-title":"Attention deficit-hyperactivity disorder is associated with allergic symptoms and low levels of hemoglobin and serotonin","volume":"8","author":"Wang LJ","year":"2018","unstructured":"Wang LJ, Yu YH, Fu ML, et al.. Attention deficit-hyperactivity disorder is associated with allergic symptoms and low levels of hemoglobin and serotonin. Sci Rep. 2018, 8:10229. 10.1038\/s41598-018-28702-5","journal-title":"Sci Rep"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204516","article-title":"Common psychiatric and metabolic comorbidity of adult attention-deficit\/hyperactivity disorder: a population-based cross-sectional study","volume":"13","author":"Chen Q","year":"2018","unstructured":"Chen Q, Hartman CA, Haavik J, et al.. Common psychiatric and metabolic comorbidity of adult attention-deficit\/hyperactivity disorder: a population-based cross-sectional study. PLoS One. 2018, 13:e0204516. 10.1371\/journal.pone.0204516","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/1087054707299402","article-title":"Psychiatric comorbidity in ADHD symptom subtypes in clinic and community adults","volume":"11","author":"Sprafkin J","year":"2007","unstructured":"Sprafkin J, Gadow KD, Weiss MD, Schneider J, Nolan EE. Psychiatric comorbidity in ADHD symptom subtypes in clinic and community adults. J Atten Disord. 2007, 11:114-24. 10.1177\/1087054707299402","journal-title":"J Atten Disord"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15020266","article-title":"Association between ADHD and obesity: a systematic review and meta-analysis","volume":"173","author":"Cortese S","year":"2016","unstructured":"Cortese S, Moreira-Maia CR, St Fleur D, Morcillo-Pe\u00f1alver C, Rohde LA, Faraone SV. Association between ADHD and obesity: a systematic review and meta-analysis. Am J Psychiatry. 2016, 173:34-43. 10.1176\/appi.ajp.2015.15020266","journal-title":"Am J Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv107","article-title":"Trajectories of body mass index and their associations with mortality among older Japanese: do they differ from those of Western populations?","volume":"182","author":"Murayama H","year":"2015","unstructured":"Murayama H, Liang J, Bennett JM, et al.. Trajectories of body mass index and their associations with mortality among older Japanese: do they differ from those of Western populations?. Am J Epidemiol. 2015, 182:597-605. 10.1093\/aje\/kwv107","journal-title":"Am J Epidemiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.02.008","article-title":"Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets","volume":"15","author":"van Hout B","year":"2012","unstructured":"van Hout B, Janssen MF, Feng YS, et al.. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012, 15:708-15. 10.1016\/j.jval.2012.02.008","journal-title":"Value Health"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2017.04.011","article-title":"The risk of injury in adults with attention-deficit hyperactivity disorder: a nationwide, matched-cohort, population-based study in Taiwan","volume":"65","author":"Chien WC","year":"2017","unstructured":"Chien WC, Chung CH, Lin FH, et al.. The risk of injury in adults with attention-deficit hyperactivity disorder: a nationwide, matched-cohort, population-based study in Taiwan. Res Dev Disabil. 2017, 65:57-73. 10.1016\/j.ridd.2017.04.011","journal-title":"Res Dev Disabil"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0000000000001805","article-title":"Improvements in workplace productivity in working patients with major depressive disorder: results from the AtWoRC study","volume":"62","author":"Chokka P","year":"2020","unstructured":"Chokka P, Tvistholm AH, Bougie J, Clerzius G, Ettrup A. Improvements in workplace productivity in working patients with major depressive disorder: results from the AtWoRC study. J Occup Environ Med. 2020, 62:e94-101. 10.1097\/JOM.0000000000001805","journal-title":"J Occup Environ Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-015-0488-8","article-title":"The incremental burden of pain in patients with depression: results of a Japanese survey","volume":"15","author":"Vietri J","year":"2015","unstructured":"Vietri J, Otsubo T, Montgomery W, Tsuji T, Harada E. The incremental burden of pain in patients with depression: results of a Japanese survey. BMC Psychiatry. 2015, 15:104. 10.1186\/s12888-015-0488-8","journal-title":"BMC Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216937","article-title":"The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program","volume":"14","author":"Waserstein G","year":"2019","unstructured":"Waserstein G, Partin C, Cohen D, Schettler P, Kinkead B, Rapaport MH. The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program. PLoS One. 2019, 14:e0216937. 10.1371\/journal.pone.0216937","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-99","article-title":"A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment","volume":"10","author":"Shaw M","year":"2012","unstructured":"Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012, 10:99. 10.1186\/1741-7015-10-99","journal-title":"BMC Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/74811-the-burden-of-undiagnosed-adults-with-attention-deficithyperactivity-disorder-symptoms-in-japan-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:21Z","timestamp":1707507381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/74811-the-burden-of-undiagnosed-adults-with-attention-deficithyperactivity-disorder-symptoms-in-japan-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.19615","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,15]]}}}